Rani Therapeutics Holdings Inc - Ordinary Shares Class A

NASDAQ:RANI   3:58:01 PM EDT
11.27
+0.50 (+4.64%)
Earnings Announcements

Rani Therapeutics Reports Q1 2022 Results

Published: 05/11/2022 20:58 GMT
Rani Therapeutics Holdings Inc - Ordinary Shares Class A (RANI) - Rani Therapeutics Reports First Quarter 2022 Financial Results; Provides Corporate Update.
Rani Therapeutics Holdings Inc - Qtrly Loss per Share $0.29.
Revenue is expected to be $0.33 Million
Adjusted EPS is expected to be -$0.71

Next Quarter Revenue Guidance is expected to be $0.33 Million
Next Quarter EPS Guidance is expected to be -$0.91

More details on our Analysts Page.